Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tenet Healthcare Corporation (THC) vs T-Mobile Us Inc (TMUS) Price & Performance

Tenet Healthcare CorporationTrade
T-Mobile Us IncTrade

Price performance (Past 24H)

Key statistics

Tenet Healthcare Corporation vs T-Mobile Us Inc — how do they compare? Tenet Healthcare Corporation trades at $264.73 (market cap $20.89B), while T-Mobile Us Inc trades at $176.4 (market cap $191.56B). The key difference: T-Mobile Us Inc is far larger — about 9.2× Tenet Healthcare Corporation's market cap, and T-Mobile Us Inc pays a 2.28% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.

THCTMUS
Market Cap
$20.89B$191.56B
Sector
HealthMedia
52-Week High
$262.63$259.01
52-Week Low
$161.37$167.65
Enterprise Value
$31.97B$308.17B
Dividend Yield
2.28%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $260.67, up 0.28% today, with strong technical momentum including a golden cross pattern and bullish moving average alignment. The company demonstrates robust fundamentals with Q2 2026 EPS beating expectations at $6.12 versus $4.26 forecast, maintaining a three-quarter earnings beat streak. Valuation metrics remain attractive with P/E of 10.03 and EV/EBITDA of 5.73, while profitability metrics show exceptional ROE of 53.31% and net margin of 9.9%.

The investment outlook remains positive with 81% analyst buy ratings and $281.44 consensus price target representing 8% upside. Key risks include policy headwinds in ACA exchanges and hospital segment challenges, though strong ambulatory growth provides offset. The stock presents a compelling value-growth combination with momentum characteristics, supported by institutional accumulation and positive earnings revisions.

T-Mobile Us Inc

TMUS trades at $176.21, down 1.09% over 24 hours, with a bearish technical signal but strong fundamentals including Q2 2026 EPS beat of $2.99 vs. $2.59 expected. Revenue grew to $88.31B in 2025, with net income of $10.99B and robust cash flow from operations of $27.95B. Recent news highlights spectrum sales and competitive threats from SpaceX's Starlink Mobile.

The outlook is mixed: analyst consensus is bullish with an $233.20 price target, but rising debt and SpaceX competition pose risks. Earnings growth and dividend increases support long-term value, though near-term volatility may persist due to technical bearishness and market sentiment shifts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC

About T-Mobile Us Inc

Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, creating T-Mobile Us. Following the merger, the firm provided nationwide service in major markets but spottier coverage elsewhere. T-Mobile spent aggressively on low-frequency spectrum, well suited to broad coverage, and has substantially expanded its geographic footprint. This expansion, coupled with aggressive marketing and innovative offerings, produced rapid customer growth. With the Sprint acquisition, the firm's scale now roughly matches its larger rivals: T-Mobile now serves 71 million postpaid and 21 million prepaid phone customers, equal to around 30% of the U.S. retail wireless market. In addition, the firm provides wholesale service to resellers.

Read more on TMUS